These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16326273)

  • 1. Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme.
    Chang CY; Li MC; Liao SL; Huang YL; Shen CC; Pan HC
    J Clin Neurosci; 2005 Nov; 12(8):930-3. PubMed ID: 16326273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducible cyclooxygenase (COX-2) in glioblastoma--clinical and immunohistochemical (COX-2-VEGF) correlations.
    Buccoliero AM; Caldarella A; Gheri CF; Taddei A; Paglierani M; Pepi M; Mennonna P; Taddei GL
    Clin Neuropathol; 2006; 25(2):59-66. PubMed ID: 16550738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients.
    Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R
    Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and prognostic value of glycosyltransferase mRNA in glioblastoma multiforme patients.
    Oblinger JL; Pearl DK; Boardman CL; Saqr H; Prior TW; Scheithauer BW; Jenkins RB; Burger PC; Yates AJ
    Neuropathol Appl Neurobiol; 2006 Aug; 32(4):410-8. PubMed ID: 16866986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Increased amounts of IL-10 mRNA in anaplastic astrocytomas and glioblastoma multiforme].
    Huettner C; Paulus W; Roggendorf W
    Verh Dtsch Ges Pathol; 1994; 78():418-22. PubMed ID: 7534012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein D expression in primary brain tumors: analysis by quantitative RT-PCR in formalin-fixed, paraffin-embedded tissue.
    Hunter SB; Varma V; Shehata B; Nolen JD; Cohen C; Olson JJ; Ou CY
    J Histochem Cytochem; 2005 Aug; 53(8):963-9. PubMed ID: 16055749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic effect of brain-specific angiogenesis inhibitor 1 on glioblastoma: an animal experiment].
    Xiao XR; Kang XX; Zhao JZ
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(19):1342-6. PubMed ID: 16796906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the prognostic value of CD44 in glioblastoma multiforme.
    Wei KC; Huang CY; Chen PY; Feng LY; Wu TW; Chen SM; Tsai HC; Lu YJ; Tsang NM; Tseng CK; Pai PC; Shin JW
    Anticancer Res; 2010 Jan; 30(1):253-9. PubMed ID: 20150644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas.
    Colin C; Voutsinos-Porche B; Nanni I; Fina F; Metellus P; Intagliata D; Baeza N; Bouvier C; Delfino C; Loundou A; Chinot O; Lah T; Kos J; Martin PM; Ouafik L; Figarella-Branger D
    Acta Neuropathol; 2009 Dec; 118(6):745-54. PubMed ID: 19774387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas.
    Huettner C; Paulus W; Roggendorf W
    Am J Pathol; 1995 Feb; 146(2):317-22. PubMed ID: 7856743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling prognosis for patients with malignant astrocytic gliomas: quantifying the expression of multiple genetic markers and clinical variables.
    Zhou YH; Hess KR; Liu L; Linskey ME; Yung WK
    Neuro Oncol; 2005 Oct; 7(4):485-94. PubMed ID: 16212813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.
    Kuan CT; Wakiya K; Dowell JM; Herndon JE; Reardon DA; Graner MW; Riggins GJ; Wikstrand CJ; Bigner DD
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1970-82. PubMed ID: 16609006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and structure of interleukin 4 receptor (IL-4R) complex in human invasive pituitary adenomas.
    Chen L; Liu Y; Hou Y; Kato Y; Sano H; Kanno T
    Neurosci Lett; 2007 Apr; 417(1):30-5. PubMed ID: 17398005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients.
    Wang LF; Fokas E; Bieker M; Rose F; Rexin P; Zhu Y; Pagenstecher A; Engenhart-Cabillic R; An HX
    Oncol Rep; 2008 Jan; 19(1):151-6. PubMed ID: 18097589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
    Razis E; Selviaridis P; Labropoulos S; Norris JL; Zhu MJ; Song DD; Kalebic T; Torrens M; Kalogera-Fountzila A; Karkavelas G; Karanastasi S; Fletcher JA; Fountzilas G
    Clin Cancer Res; 2009 Oct; 15(19):6258-66. PubMed ID: 19789313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: an unexpected prognostic significance?
    Kren L; Slaby O; Muckova K; Lzicarova E; Sova M; Vybihal V; Svoboda T; Fadrus P; Lakomy R; Vanhara P; Krenova Z; Sterba J; Smrcka M; Michalek J
    Neuropathology; 2011 Apr; 31(2):129-34. PubMed ID: 20667016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis.
    Reddy SP; Britto R; Vinnakota K; Aparna H; Sreepathi HK; Thota B; Kumari A; Shilpa BM; Vrinda M; Umesh S; Samuel C; Shetty M; Tandon A; Pandey P; Hegde S; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Kondaiah P; Somasundaram K; Rao MR
    Clin Cancer Res; 2008 May; 14(10):2978-87. PubMed ID: 18483363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ki-67 expression in operable breast cancer: a comparative study of immunostaining and a real-time RT-PCR assay.
    Potemski P; Pluciennik E; Bednarek AK; Kusinska R; Kubiak R; Jesionek-Kupnicka D; Watala C; Kordek R
    Pathol Res Pract; 2006; 202(7):491-5. PubMed ID: 16678980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of c-Met expression in glioblastomas.
    Kong DS; Song SY; Kim DH; Joo KM; Yoo JS; Koh JS; Dong SM; Suh YL; Lee JI; Park K; Kim JH; Nam DH
    Cancer; 2009 Jan; 115(1):140-8. PubMed ID: 18973197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures.
    Joshi BH; Leland P; Asher A; Prayson RA; Varricchio F; Puri RK
    Cancer Res; 2001 Nov; 61(22):8058-61. PubMed ID: 11719427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.